Cited by 569Menopause: Health Impacts and TreatmentsVenous Thromboembolism Diagnosis and ManagementCerebral Venous Sinus Thrombosis

The DOI matches its Crossref record; 72 of the 73 references it cites were found in a registry or an index.

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis

Open access

Canonico, Marianne, Plu-Bureau, Geneviève, Lowe, Gordon D O, Scarabin, Pierre-Yves·2008·BMJ

DOI 10.1136/bmj.39555.441944.bePMC PMC2405857

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: To assess the risk of venous thromboembolism in women using hormone replacement therapy by study design, characteristics of the therapy and venous thromboembolism, and clinical background. DESIGN: Systematic review and meta-analysis. DATA SOURCES: Medline. STUDIES REVIEWED: Eight observational studies and nine randomised controlled trials. INCLUSION CRITERIA: Studies on hormone replacement therapy that reported venous thromboembolism. REVIEW MEASURES: Homogeneity between studies was analysed using chi(2) and I(2) statistics. Overall risk of venous thromboembolism was assessed from a fixed effects or random effects model. RESULTS: Meta-analysis of observational studies showed that oral oestrogen but not transdermal oestrogen increased the risk of venous thromboembolism. Compared with non-users of oestrogen, the odds ratio of first time venous thromboembolism in current users of oral oestrogen was 2.5 (95% confidence interval 1.9 to 3.4) and in current users of transdermal oestrogen was 1.2 (0.9 to 1.7). Past users of oral oestrogen had a similar risk of venous thromboembolism to never users. The risk of venous thromboembolism in women using oral oestrogen was higher in the first year of treatment (4.0, 2.9 to 5.7) compared with treatment for more than one year (2.1, 1.3 to 3.8; P<0.05). No noticeable difference in the risk of venous thromboembolism was observed between unopposed oral oestrogen (2.2, 1.6 to 3.0) and opposed oral oestrogen (2.6, 2.0 to 3.2). Results from nine randomised controlled trials confirmed the increased risk of venous thromboembolism among women using oral oestrogen (2.1, 1.4 to 3.1). The combination of oral oestrogen and thrombogenic mutations or obesity further enhanced the risk of venous thromboembolism, whereas transdermal oestrogen did not seem to confer additional risk in women at high risk of venous thromboembolism. CONCLUSION: Oral oestrogen increases the risk of venous thromboembolism, especially during the first year of treatment. Transdermal oestrogen may be safer with respect to thrombotic risk. More data are required to investigate differences in risk across the wide variety of hormone regimens, especially the different types of progestogens.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/bmj.39555.441944.be

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy: The Women's Health Initiative Randomized Controlled Trial
(2004) · JAMA · doi:10.1001/jama.291.14.1701 · Cited by 4,534
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560
QUANTITATIVE METHODS IN THE REVIEW OF EPIDEMIOLOGIC LITERATURE1
GREENLAND, S. (1987) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036298 · Cited by 1,644
Shape of the relapse curve and long-term abstinence among untreated smokers
Hughes, J. R., Keely, J., & Naud, S. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00540.x · Cited by 1,414
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352

Show all 73 references

Research works printed but not linked: 2

Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12.
Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res 1993;2:121-45.

Sorted by citations

Items 201–300 of 567

A Review of Transdermal Nonpatch Estrogen Therapy for the Management of Menopausal Symptoms
Carroll, N. (2010) · Journal of Women s Health · doi:10.1089/jwh.2008.1206 · Cited by 23
Effect of NFE2L2 Genetic Polymorphism on the Association Between Oral Estrogen Therapy and the Risk of Venous Thromboembolism in Postmenopausal Women
Bouligand, J., Cabaret, O., Canonico, M., Verstuyft, C., Dubert, L., Becquemont, L., Guiochon‐Mantel, A., & Scarabin, P. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.241 · Cited by 23
Self-citation
Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions
Mukherjee, A., & Davis, S. R. (2025) · Clinical Endocrinology · doi:10.1111/cen.15211 · Cited by 31
Significant fall in hormone replacement therapy prescription in general practice
Lagro-Janssen, A. L. M., Knufing, M. W. A., Schreurs, L., & van Weel, C. (2010) · Family Practice · doi:10.1093/fampra/cmq018 · Cited by 22
A model to assess the risk of peripherally inserted central venous catheter-related thrombosis in patients with breast cancer: a retrospective cohort study
Peng, S., Wei, T., Li, X., Yuan, Ž., & Lin, Q. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06511-3 · Cited by 22
From the Women’s Health Initiative to the combination of estrogen and selective estrogen receptor modulators to avoid progestin addition
Valera, M., Gourdy, P., Trémollières, F., & Arnal, J. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.07.012 · Cited by 22
Transfeminine Hormone Therapy
Hamidi, O., & Davidge-Pitts, C. J. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.02.001 · Cited by 23
Pharmacokinetics of Sublingual Versus Oral Estradiol in Transgender Women
Doll, E., Gunsolus, I. L., Thorgerson, A. A., Tangpricha, V., Lamberton, N., & Sarvaideo, J. L. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.11.081 · Cited by 21
Reproductive history, hormone replacement, and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology
Ohira, T., Folsom, A. R., Cushman, M., White, R. H. R., Hannan, P. J., Rosamond, W. D., & Heckbert, S. R. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08128.x · Cited by 21
Overview and assessment of risk factors for pulmonary embolism
Hoo, G. W. S. (2013) · Expert Review of Respiratory Medicine · doi:10.1586/ers.13.7 · Cited by 21
Venous Thromboembolism Issues in Women
Linnemann, B., Rott, H., Zotz, R. B., & Hart, C. (2022) · Hämostaseologie · doi:10.1055/a-1919-9558 · Cited by 20
Comparison of Pooled Risk Estimates for Adverse Effects from Different Observational Study Designs: Methodological Overview
Golder, S., Loke, Y. K., & Bland, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071813 · Cited by 20
Estrogens as first-choice therapy for osteoporosis prevention and treatment in women under 60
Studd, J. W. W. (2009) · Climacteric · doi:10.1080/13697130902721873 · Cited by 20
Optimizing Fertility in Primary Ovarian Insufficiency: Case Report and Literature Review
Piedade, K. C., Spencer, H., Persani, L., & Nelson, L. M. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.676262 · Cited by 21
Informing women about hormone replacement therapy: the consensus conference statement
Consensus Conference Working Group, Mosconi, P., Donati, S., Colombo, C., Mele, A., Liberati, A., & Satolli, R. (2009) · BMC Women s Health · doi:10.1186/1472-6874-9-14 · Cited by 21
Impact of route of administration on genotoxic oestrogens concentrations using oral vs transdermal oestradiol in girls with Turner syndrome
Mauras, N., Torres‐Santiago, L., Santen, R., Mericq, V., Ross, J., Colon‐Otero, G., Damaso, L., Hossain, J., Wang, Q., Mesaros, C., et al. (2019) · Clinical Endocrinology · doi:10.1111/cen.13869 · Cited by 19
What if the Women’s Health Initiative had used transdermal estradiol and oral progesterone instead?
Simon, J. A. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000169 · Cited by 19
The Effect of Perimenopausal Transdermal Estradiol and Micronized Progesterone on Markers of Risk for Arterial Disease
Gordon, J. L., Rubinow, D. R., Watkins, L. L., Hinderliter, A. L., Caughey, M. C., & Girdler, S. S. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz262 · Cited by 19
Nocturia through the menopausal transition and beyond: a narrative review
Pauwaert, K., Goessaert, A., Ghijselings, L., Monaghan, T. F., Depypere, H. T., & Everaert, K. (2021) · International Urogynecology Journal · doi:10.1007/s00192-020-04640-7 · Cited by 20
The Smallest Available Estradiol Transdermal Patch: A New Treatment Option for the Prevention of Postmenopausal Osteoporosis
Bertonazzi, A., Nelson, B., Salvador, J., & Umland, E. M. (2015) · Women s Health · doi:10.2217/whe.15.64 · Cited by 19
Update: Estrogen and Estrogen plus Progestin Therapy in the Care of Women at and after the Menopause
Davey, D. A. (2012) · Women s Health · doi:10.2217/whe.12.1 · Cited by 18
Attitude of German gynecologists towards prescribing HRT before and after the WHI study
Bühling, K. J., von Studnitz, F. S. G., Jantke, A., Eulenburg, C., & Mueck, A. O. (2011) · Climacteric · doi:10.3109/13697137.2011.631061 · Cited by 18
The choice of progestogen for HRT in menopausal women: breast cancer risk is a major issue
Ruan, X., & Mueck, A. O. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2018-0019 · Cited by 18
Postmenopausal hormone therapy and cardiovascular disease in women
Stefanick, M. L. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.02.015 · Cited by 17
Hormone replacement therapy leads to increased plasma levels of platelet derived microparticles in postmenopausal women
Rank, A., Nieuwland, R., Nikolajek, K., Rösner, S., Wallwiener, L.-M., Hiller, E., & Tóth, B. (2011) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-2098-0 · Cited by 18
Primary Prevention of Cardiovascular Disease with HRT
Maclaran, K., & Stevenson, J. C. (2011) · Women s Health · doi:10.2217/whe.11.87 · Cited by 18
Risk factors and new inflammatory indicators of deep vein thrombosis after adult patella fractures
Diao, S., Li, J., Zhao, J., Wang, D., Wang, H., Xu, X., & Zhou, J. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.1028542 · Cited by 17
Long-term cross-sex hormone treatment is safe in transsexual subjects
Meriggiola, M. C., & Berra, M. (2012) · Asian Journal of Andrology · doi:10.1038/aja.2012.89 · Cited by 17
Chinese herbal medicine Kuntai capsule for treatment of menopausal syndrome: a systematic review of randomized clinical trials
Zhou, Q., Tao, J., Song, H., Chen, A., Yang, H.-J., Zuo, M., & Li, H. (2016) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2016.09.011 · Cited by 17
Are Some Types of Hormone Therapy Safer Than Others?
Rexrode, K. M., & Manson, J. E. (2007) · Circulation · doi:10.1161/circulationaha.106.675405 · Cited by 17
Use of Hormone Therapy in Postmenopausal Women with Alzheimer’s Disease: A Systematic Review
Cardinali, C. A. E. F., Martins, Y. A., & Torrão, A. D. S. (2021) · Drugs & Aging · doi:10.1007/s40266-021-00878-y · Cited by 16
Menopausal symptom management in women with cardiovascular disease or vascular risk factors
Hirsch, H., & Manson, J. E. (2022) · Maturitas · doi:10.1016/j.maturitas.2022.01.016 · Cited by 16
Transdermal estrogen gel vs oral estrogen after hysteroscopy for intrauterine adhesion separation: A prospective randomized study
Yi, T., Zhang, X., Gupta, V., Li, L., & Zhong, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1066210 · Cited by 16
Thromboembolic risk with gender-affirming hormone therapy: potential role of global coagulation and fibrinolysis assays
Bouck, E. G., Grinsztejn, E., McNamara, M., Stavrou, E. X., & Wolberg, A. S. (2023) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2023.102197 · Cited by 16
Cardiovascular health in the menopausal woman: impact of the timing of hormone replacement therapy
Rosano, G. M. C., Vitale, C., Spoletini, I., & Fini, M. (2012) · Climacteric · doi:10.3109/13697137.2012.658899 · Cited by 17
Effects of Hot Water Extracts from Polygonum multiflorum on Ovariectomy Induced Osteopenia in Mice
Hwang, Y.-H., Kang, K.-Y., Kim, J.-J., Lee, S.-J., Son, Y., Paik, S., & Yee, S. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/8970585 · Cited by 16
Women, thrombosis, and cancer
Farge, D., Maignan, C. L., Doucet, L. S., & Frère, C. (2019) · Thrombosis Research · doi:10.1016/s0049-3848(19)30367-6 · Cited by 17
Association of Genetically Predicted Serum Estradiol With Risk of Thromboembolism in Men: A Mendelian Randomization Study
Nethander, M., Quester, J., Vandenput, L., & Ohlsson, C. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab164 · Cited by 16
Hormone Replacement Therapy in the Geriatric Patient: Current State of the Evidence and Questions for the Future. Estrogen, Progesterone, Testosterone, and Thyroid Hormone Augmentation in Geriatric Clinical Practice: Part 1
Schwartz, E., & Holtorf, K. (2011) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2011.07.013 · Cited by 16
Application of biomaterials in mesenchymal stem cell based endometrial reconstruction: current status and challenges
He, L., & Li, Q. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1518398 · Cited by 15
Soybean concentrated extract counteracts oxidative stress in the uterus of rats
Teixeira, C. P., Simões, R. S., dos Santos, M. A. B., Calió, M. L., Soares, J. M., Simões, M. D. J., Bertoncini, C. R. A., Higa, E. M. S., & Carbonel, A. A. F. (2013) · Climacteric · doi:10.3109/13697137.2013.856402 · Cited by 15
Associations of Urinary Phytoestrogen Concentrations with Sleep Disorders and Sleep Duration among Adults
Sun, J., Jiang, H. F., Wang, W., Dong, X. Z., & Zhang, D. (2020) · Nutrients · doi:10.3390/nu12072103 · Cited by 16
Which Hormones and Contraception for Women with APS? Exogenous Hormone Use in Women with APS
Sammaritano, L. R. (2021) · Current Rheumatology Reports · doi:10.1007/s11926-021-01006-w · Cited by 16
Benefits and risks during HRT: main safety issue breast cancer
Mueck, A. O., & Ruan, X. (2011) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2011.014 · Cited by 15
Antiplatelet Therapy Use and the Risk of Venous Thromboembolic Events in the Raloxifene Use for the Heart (RUTH) Trial
Duvernoy, C. S., Yeo, A. A., Wong, M., Cox, D. A., & Kim, H. M. (2010) · Journal of Women s Health · doi:10.1089/jwh.2009.1687 · Cited by 15
Recurrence risk of venous thromboembolism and hormone use in women from England: a cohort study using clinical practice research datalink
Kiconco, S., Sultan, A. A., & Grainge, M. J. (2017) · British Journal of Haematology · doi:10.1111/bjh.14516 · Cited by 15
Cancer-Associated Thrombosis: A New Light on an Old Story
Shah, S., Karathanasi, A., Revythis, A., Ioannidou, E., & Boussios, S. (2021) · Diseases · doi:10.3390/diseases9020034 · Cited by 15
Oral versus transdermal oestrogen delivery for endometrial preparation before embryo transfer: a prospective, comparative, randomized clinical trial
Ferrer-Molina, P., Lliso, C. C., Carreras, R., Muñoz-García, M., Díaz-Bachiller, M., Blanes-Espí, J., & Checa, M. Á. (2018) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2018.09.003 · Cited by 14
Brazilian Guideline on Menopausal Cardiovascular Health – 2024
de Oliveira, G. M. M., de Almeida, M. C. C., Artucio, C., Espíndola, L. N., Rivera, M. A. M., Filho, A. L. D. S., Marques-Santos, C., Fernandes, C. E., Albuquerque, C. J. D. M., Freire, C. M. V., et al. (2024) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20240478i · Cited by 17
Evolution of postmenopausal hormone therapy between 2002 and 2009
Ettinger, B. B., Wang, S. M., Leslie, R. S., Patel, B. V., Boulware, M. J., Mann, M. E., & McBride, M. (2018) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001233 · Cited by 14
Risk of venous thromboembolism by route of administration of estrogen
Løbo, R. A. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318211745b · Cited by 14
Effects of either Tibolone or Continuous Combined Transdermal Estradiol with Medroxyprogesterone Acetate on Coagulatory Factors and Lipoprotein(a) in Menopause
Perrone, G., Capri, O., Galoppi, P., Brunelli, R., Bevilacqua, E., Ceci, F., Ciarla, M. V., & Ström, R. (2009) · Gynecologic and Obstetric Investigation · doi:10.1159/000211676 · Cited by 13
The endometrial and breast safety of menopausal hormone therapy containing micronised progesterone: A short review
Eden, J. (2017) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12583 · Cited by 13
Management of Menopausal Symptoms for Women Who Are at High Risk of Thrombosis
Pinkerton, J. V., & James, A. (2018) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000358 · Cited by 13
Cardiovascular Risk/Benefit Profile of MHT
Villa, P., Amar, I. D., Shachor, M., Cipolla, C., Ingravalle, F., & Scambia, G. (2019) · Medicina · doi:10.3390/medicina55090571 · Cited by 13
Effects of continuous combined hormone replacement therapy and clodronate on bone mineral density in osteoporotic postmenopausal women: A 5-year follow-up
Tuppurainen, M. T., Härmä, K., Komulainen, M. H., Kiviniemi, V. V., Kröger, H., Honkanen, R., Alhava, E. M., Jurvelin, J. S., & Saarikoski, S. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.04.013 · Cited by 13
Menopausal symptoms.
Burbos, N., & Morris, E. P. (2011) · Europe PMC (PubMed Central) · Cited by 13
The 2025 Menopausal Hormone Therapy Guidelines - Korean Society of Menopause
Kim, Y. J., Cho, M. K., Chung, Y., Hong, S.-H., Hwang, K. R., Jeon, G., Joo, J. K., Kim, S. K., Lee, D. O., Lee, D., et al. (2025) · Journal of Menopausal Medicine · doi:10.6118/jmm.25103 · Cited by 17
Therapeutic strategy for exosome-based bone regeneration to osteoporosis: Challenges and potential solutions
Dayanandan, A. P., Bello, A. B., Arai, Y., Lee, S. J., & Lee, S.-H. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.09.042 · Cited by 18
Evaluation of thromboprophylaxis in medium-sized general hospital
Busato, C. R., Gomes, R. Z., Costa, D. M. D. M., & Zubiolo, T. F. M. (2014) · Jornal Vascular Brasileiro · doi:10.1590/jvb.2014.003 · Cited by 12
Oral estradiol/micronized progesterone may be associated with lower risk of venous thromboembolism compared with conjugated equine estrogens/medroxyprogesterone acetate in real-world practice
Panay, N., Nappi, R. E., Stute, P., Palacios, S., Paszkowski, T., Kagan, R., Archer, D. F., Héroux, J., & Boolell, M. (2023) · Maturitas · doi:10.1016/j.maturitas.2023.04.004 · Cited by 12
The pathophysiology of estrogen in perinatal depression: conceptual update
Nielsen, A. M., Stika, C. S., & Wisner, K. L. (2024) · Archives of Women s Mental Health · doi:10.1007/s00737-024-01494-6 · Cited by 14
Insights Into the Cardiomodulatory Effects of Sex Hormones: Implications in Transgender Care
Shawky, N. M., Reckelhoff, J. F., Alexander, B. T., & Cardozo, L. L. Y. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.19501 · Cited by 13
Should transdermal rather than oral estrogens be used in menopausal hormone therapy?: a review
Fournier, A. (2010) · Menopause international · doi:10.1258/mi.2010.010009 · Cited by 12
How do you decide on hormone replacement therapy in women with risk of venous thromboembolism?
Leković, D., Miljić, P., Dmitrović, A., & Thachil, J. V. (2016) · Blood Reviews · doi:10.1016/j.blre.2016.12.001 · Cited by 12
Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database
Hasegawa, S., Matsui, T., Hane, Y., Abe, J., Hatahira, H., Motooka, Y., Sasaoka, S., Fukuda, A., Naganuma, M., Hirade, K., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182045 · Cited by 12
Difference in the expression of inflammatory mediators in gingival crevicular fluid in postmenopausal patients with chronic periodontitis with and without menopausal hormone therapy
Arias-Herrera, S., Bascones-Ilundian, C., & Martínez, A. B. (2019) · European Journal of Obstetrics & Gynecology and Reproductive Biology X · doi:10.1016/j.eurox.2019.100021 · Cited by 12
Discontinuation of hormone therapy in the French GAZEL cohort 1990–2006
Ringa, V., Fritel, X., Varnoux, N., Zins, M., Quelen, C., & Bouyer, J. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.07.1001 · Cited by 12
Menopausal hormone therapy for breast cancer patients: what is the current evidence?
Glynne, S., Simon, J. A., Branson, A., Payne, S. J., Newson, L. R., Manyonda, I., Cleator, S. J., Douek, M., USISKIN, S. I., Tobias, J. S., et al. (2025) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002627 · Cited by 12
No Thromboembolic Complications After Facial Feminization Surgery in Transgender Patients Utilizing Estrogen Therapy: A Retrospective Cohort Study
Price, R., Debryn, D., Mukerji, S., Nozari, A., Spiegel, J. H., & Kim, E. S. (2022) · Transgender Health · doi:10.1089/trgh.2021.0170 · Cited by 11
Prevention of osteoporosis: one step forward, two steps back
Stevenson, J. C. (2011) · Menopause international · doi:10.1258/mi.2011.011112 · Cited by 11
Women, thrombosis, and cancer: A gender-specific analysis
Farge, D., Bounameaux, H., Bauersachs, R. M., & Brenner, B. (2017) · Thrombosis Research · doi:10.1016/s0049-3848(17)30062-2 · Cited by 11
“Affirming” journey: Narrative review and practice considerations on gender affirming care
Mills, A. R., Astle, K., & Frazier, C. C. (2022) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1621 · Cited by 11
Thrombophilia and hormonal therapy in transgender persons: A literature review and case series
Marianne, K., Vantilborgh, A., Collet, S., & T'Sjoen, G. G. (2022) · International Journal of Transgender Health · doi:10.1080/26895269.2022.2025551 · Cited by 10
Venous Thromboembolism and Estrogen-Containing Gender-Affirming Hormone Therapy
Dix, C. H. K., Moloney, M., Tran, H. A., & McFadyen, J. D. (2023) · Thrombosis and Haemostasis · doi:10.1055/a-2188-8898 · Cited by 13
Hormone Therapy in the Era of the COVID-19 Pandemic: A Review
Choi, S. W., Kim, J., Lee, J. H., Kim, S. K., Lee, S. R., Kim, S. H., & Chae, H. D. (2022) · Journal of Menopausal Medicine · doi:10.6118/jmm.21036 · Cited by 10
Controversies Regarding Postmenopausal Hormone Replacement Therapy for Primary Cardiovascular Disease Prevention in Women
Taylor, J. E., Baig, M. S., Helmy, T. A., & Gersh, F. L. (2020) · Cardiology in Review · doi:10.1097/crd.0000000000000353 · Cited by 10
Antiosteoporosis Activity of New Oriental Medicine Preparation (Kyungokgo Mixed with Water Extract of Hovenia dulcis ) on the Ovariectomized Mice
Hwang, Y.-H., Kim, K., Kim, J.-J., Kang, K.-Y., Lee, S.-J., Jeong, G.-Y., Choi, K., Son, Y., & Yee, S. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/373145 · Cited by 10
Hospitalization for pulmonary embolism associated with antecedent testosterone or estrogen therapy in patients found to have familial and acquired thrombophilia
Prince, M., Glueck, C. J., Shah, P. K., Kumar, A., Goldenberg, M., Rothschild, M., Motayar, N., Jetty, V., Lee, K., & Wang, P. (2016) · BMC Hematology · doi:10.1186/s12878-016-0045-9 · Cited by 10
Hormone therapy in postmenopausal women associated with risk of stroke and venous thromboembolism: a population-based cohort study in Taiwan
Chang, W., Wang, J., & Ding, D. (2018) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001182 · Cited by 10
Puberty
Witchel, S. F., & Plant, T. M. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00018-4 · Cited by 10
Tromboembolismo venoso na mulher: novos desafios para uma velha doença
de Oliveira, A. L. M. L., Paschôa, A. F., & Marques, M. A. (2020) · Jornal Vascular Brasileiro · doi:10.1590/1677-5449.190148 · Cited by 13
Self-Reported Changes in Providers' Hormone Therapy Prescribing and Counseling Practices After the Women's Health Initiative
Lakey, S. L., Reed, S. D., LaCroix, A. Z., Grothaus, L. C., & Newton, K. M. (2010) · Journal of Women s Health · doi:10.1089/jwh.2010.2047 · Cited by 10
Epidemiology of hormone-related venous thromboembolism
Middeldorp, S. (2009) · Thrombosis Research · doi:10.1016/s0049-3848(09)70014-3 · Cited by 10
Postmenopausal hormone therapy and the risk of cardiovascular disease
Bittner, V. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903066829 · Cited by 10
Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception
Tanratana, P., Ellery, P. E. R., Westmark, P. R., Mast, A. E., & Sheehan, J. P. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309919 · Cited by 10
Withholding of Hormone Replacement Therapy Prior to Total Joint Arthroplasty Surgery to Reduce the Risk of Postoperative Thromboembolic Events: Is It Justified?—A Systematic Review of Clinical Practice Guidelines
Abouharb, A., Mehta, S., Rathnayake, H., & Pandit, H. G. (2023) · The Journal of Arthroplasty · doi:10.1016/j.arth.2023.08.061 · Cited by 11
Lifestyle Management in Menopause: A Systematic Review of Women With Premature Ovarian Insufficiency
Yeganeh, L., Vermeulen, N., Ee, C., Teede, H. J., & Vincent, A. J. (2025) · Clinical Endocrinology · doi:10.1111/cen.15218 · Cited by 9
Premature ovarian insufficiency: When ovaries retire early
Sugianto, S. R. S., Webber, L. J., Safdar, F., Viardot-Foucault, V., Nadarajah, S., Lim, J. Y., Tan, E. S., Yong, T. T., & Puvanendran, R. (2025) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.2024227 · Cited by 9
Transgender Medicine and Risk of Venous Thromboembolism
van Bunderen, C. C., Leentjens, J., & Middeldorp, S. (2022) · Hämostaseologie · doi:10.1055/a-1891-8158 · Cited by 9
Interaction between oral estrogen plus progestogen therapy and ABO blood groups on coagulation activation in postmenopausal women
Guimarães, D. A. M., dos Santos, M. S., Gomes, K. B., van der Bom, J. G., Rios, D. R. A., Cardoso, J. E., Franco, R. M., Teixeira, G. D. S., Dusse, L. M. S., Ferriani, M. D. G. C., et al. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31822b721f · Cited by 9
Herbal medicines for menopausal symptoms
Wuttke, W., & Seidlová‐Wuttke, D. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.02.064 · Cited by 9
Norethisterone acetate alters coagulation gene expression in vitro in human cell culture
Brosnan, J. F., SHEPPARD, B. L., Kelly, L. A., O’Leary, J. J., & Norris, L. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.09.006 · Cited by 9
Recurrent venous thromboembolism and vaginal estradiol in women with prior venous thromboembolism: A nested case–control study
Eckert‐Lind, C., Meaidi, A., Claggett, B. L., Johansen, N. D., Lassen, M. C. H., Skaarup, K. G., Fralick, M., Pareek, M., Jensen, J. S., Torp-Pedersen, C. T., et al. (2024) · European Journal Of Haematology · doi:10.1111/ejh.14287 · Cited by 8
The Impact of Hormone Replacement Therapy on the Risk of Heart Failure in Postmenopausal Women: A Meta‐Analysis of Clinical and Observational Studies
Arayıcı, M. E., Kılıç, M. E., & Yılmaz, M. B. (2024) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70029 · Cited by 8
Determination of the use of complementary and alternative medicine by women in the climacteric period in the Turkish city of Samsun
Koç, Z., Sağlam, Z., & Topatan, S. (2013) · Contemporary Nurse · doi:10.5172/conu.2013.45.2.197 · Cited by 8
Hormone Therapy and Risk of Venous Thromboembolism Among Postmenopausal Women in Taiwan – A 10-Year Nationwide Population-Based Study –
Lee, C., Cheng, C., Yang, Y. K., & Lin, L.-J. (2015) · Circulation Journal · doi:10.1253/circj.cj-14-1227 · Cited by 8
Clinical efficacy of estradiol transdermal system in the treatment of hot flashes in postmenopausal women
Castelo‐Branco, C., & Soveral, I. (2014) · Research and Reports in Transdermal Drug Delivery · doi:10.2147/rrtd.s47532 · Cited by 8
Pulmonary embolism in menopausal hormone therapy: a population-based register study
Sundell, M., Holm, A.-C., Fredrikson, M. G., Hammar, M. L., Hoffmann, M., & Brynhildsen, J. (2022) · Climacteric · doi:10.1080/13697137.2022.2127352 · Cited by 8
Smart Talk on Supplements and Botanicals
Dog, T. L. (2008) · Alternative and Complementary Therapies · doi:10.1089/act.2008.14502 · Cited by 8

Authors: Canonico, M., Plu-Bureau, G., Lowe, G. D. O., & Scarabin, P.-Y.
Affiliations: Université Paris-Sud (FR)
Glasgow Royal Infirmary (GB)
Corresponding author: Canonico, Marianne
ORCID: Canonico, Marianne
Lowe, Gordon D O
Scarabin, Pierre-Yves
Venue: BMJ
Publisher: BMJ
Published: 2008-05-20
Volume: 336
Issue: 7655
Pages: 1227-1231
ISSN: 0007-1447 (ISSN-L)
0959-8138
1468-5833
DOI: 10.1136/bmj.39555.441944.be
PMC: PMC2405857
OpenAlex: W2008660261
Cited by: 569
References: 73
Citations by year: 2026: 25 · 2025: 31 · 2024: 20 · 2023: 17 · 2022: 29 · 2021: 30 · 2020: 21 · 2019: 29 · 2018: 27 · 2017: 26 · 2016: 30 · 2015: 28 · 2014: 32 · 2013: 45 · 2012: 35
FWCI: 6.50
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.bmj.org/licenses/tdm/1.0/terms-and-conditions.html (tdm)
Locations: BMJ (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion, other-oa)
HighWire Press Open Archive (submittedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Health Sciences › Medicine › Clinical Neurology › Cerebral Venous Sinus Thrombosis
Keywords: hormone replacement therapy, venous thromboembolism, postmenopausal women, oral estrogen, transdermal estrogen, obesity, unopposed estrogen, progestogens, thrombosis risk, treatment duration
MeSH terms: Administration, Cutaneous, Administration, Oral, Female, Humans, Risk, Risk Factors, Estrogen Replacement Therapy, Randomized Controlled Trials as Topic, Postmenopause, Venous Thromboembolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks